Current Report Filing (8-k)
February 10 2022 - 3:07PM
Edgar (US Regulatory)
0000788611
false
0000788611
2022-02-10
2022-02-10
0000788611
SGLB:CommonStockParValue0.001PerShareMember
2022-02-10
2022-02-10
0000788611
SGLB:WarrantsToPurchaseCommonStockParValue0.001PerShareMember
2022-02-10
2022-02-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): February 10, 2022
SIGMA
LABS, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
001-38015
|
|
27-1865814
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
3900
Paseo del Sol
Santa
Fe, New Mexico 87507
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code: (505) 438-2576
Former
name or former address, if changed since last report
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐
|
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common Stock, par value
$0.001 per share
|
|
SGLB
|
|
The NASDAQ Stock Market
LLC
|
Warrants to Purchase Common
Stock, par value $0.001 per share
|
|
SGLBW
|
|
The NASDAQ Stock Market
LLC
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On
February 10, 2022, Sigma Labs, Inc. (the “Company”) issued a press release regarding the upcoming expiration, delisting and
deregistration of the Company’s outstanding warrants to purchase common stock (Nasdaq: SGLBW), a copy of which is attached hereto
as Exhibit 99.1 and incorporated herein by reference.
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: February 10, 2022
|
SIGMA LABS, INC.
|
|
|
|
|
By:
|
/s/ Mark
K. Ruport
|
|
Name:
|
Mark K. Ruport
|
|
Title:
|
President and Chief Executive Officer
|
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Jul 2023 to Jul 2024